Skip to Main Content
Table 2—

Relative risks of all-cause and CVD mortality associated with the NCEP, NCEP-R, and IDF definitions of the metabolic syndrome in 20,789 men 20–83 years of age from the ACLS

nNo. deaths (CVD)Man-years of follow-upAll-cause mortality
CVD mortality
RR (95% CI)*RR (95% CI)RR (95% CI)*RR (95% CI)
NCEP        
    No 16,692 449 (134) 193,748 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 
    Yes 4,097 183 (79) 43,063 1.46 (1.23–1.74) 1.36 (1.14–1.62) 2.03 (1.54–2.69) 1.79 (1.35–2.37) 
NCEP-R        
    No 15,194 399 (118) 177,515 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 
    Yes 5,595 233 (95) 59,296 1.41 (1.21–1.67) 1.31 (1.11–1.54) 1.89 (1.44–2.47) 1.67 (1.27–2.19) 
IDF        
    No 14,546 385 (112) 170,780 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 
    Yes 6,243 247 (101) 66,030 1.36 (1.16–1.60) 1.26 (1.07–1.49) 1.86 (1.42–2.44) 1.67 (1.27–2.20) 
nNo. deaths (CVD)Man-years of follow-upAll-cause mortality
CVD mortality
RR (95% CI)*RR (95% CI)RR (95% CI)*RR (95% CI)
NCEP        
    No 16,692 449 (134) 193,748 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 
    Yes 4,097 183 (79) 43,063 1.46 (1.23–1.74) 1.36 (1.14–1.62) 2.03 (1.54–2.69) 1.79 (1.35–2.37) 
NCEP-R        
    No 15,194 399 (118) 177,515 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 
    Yes 5,595 233 (95) 59,296 1.41 (1.21–1.67) 1.31 (1.11–1.54) 1.89 (1.44–2.47) 1.67 (1.27–2.19) 
IDF        
    No 14,546 385 (112) 170,780 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 
    Yes 6,243 247 (101) 66,030 1.36 (1.16–1.60) 1.26 (1.07–1.49) 1.86 (1.42–2.44) 1.67 (1.27–2.20) 
*

Adjusted for age and year of examination.

Adjusted for age, year of examination, smoking, alcohol consumption, parental history of premature CVD, and possible CVD at baseline.

Close Modal

or Create an Account

Close Modal
Close Modal